Abstract
The oral manifestations of bacterial diseases are varied ranging from nonspecific ulcers to the nearly pathognomonic strawberry tongue of scarlet fever. The bacterial diseases with oral manifestations range from the highly prevalent gingivitis/periodontitis to the much rarer diphtheria, a disease physicians in North America would not expect to encounter. This chapter covers the salient features of the following bacterial diseases with emphasis on their oral manifestations: syphilis, gonorrhea, tuberculosis, acute necrotizing ulcerative gingivitis, scarlet fever, diphtheria, staphylococcal scalded skin, leprosy, gingivitis/periodontitis, granuloma inguinale, tularemia, and cat scratch disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Goldman L, Schafter AI, editors. Cecil medicine: expert consult – online. Philadelphia: Elsevier Health Sciences; 2011.
Goldman L, Schafter AI, editors. Goldman’s Cecil medicine. 24th ed. Philadelphia: Elsevier Saunders; 2012.
James WD, Berger T, Elston D. Andrew’s diseases of the skin: clinical dermatology. Philadelphia: Elsevier Health Sciences; 2011.
Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Philadelphia: Churchill Livingstone/Elsevier; 2010.
Bolognia JL, Jorizzo JL, Schaffer JV. Dermatology. UK: Elsevier Health Sciences; 2012.
Andreoli TE, et al. Andreoli and Carpenter’s Cecil essentials of medicine. Philadelphia: Elsevier Health Sciences; 2010.
Schwarzenberger K, Werchniak AE, Ko CJ, editors. General dermatology. Edinburgh: Elsevier Limited; 2009.
Goering RV, Mims CA. Mims’ medical microbiology. Philadelphia: Mosby Elsevier; 2008.
Leuci S, Martina S, Adamo D, Ruoppo E, Santarelli A, Sorrentino R, et al. Oral syphilis: a retrospective analysis of 12 cases and a review of the literature. Oral Dis. 2013;19(8):738–46. https://doi.org/10.1111/odi.12058.
Kent ME, Romanelli F. Reexamining syphilis: an update on epidemiology, clinical manifestations, and management. Ann Pharmacother. 2008;42(2):226–36. https://doi.org/10.1345/aph.1K086.
Drago F, Ciccarese G, Cogorno L, Tomasini CF, Cozzani EC, Riva SF, et al. Primary syphilis of the oropharynx: unusual location of a chancre. Int J STD AIDS. 2014; https://doi.org/10.1177/0956462414551235.
Hertel M, Matter D, Schmidt-Westhausen AM, Bornstein MM. Oral syphilis: a series of 5 cases. J Oral Maxillofac Surg. 2014;72(2):338–45. https://doi.org/10.1016/j.joms.2013.07.015.
Ficarra G, Carlos R. Syphilis: the renaissance of an old disease with oral implications. Head Neck Pathol. 2009;3(3):195–206. https://doi.org/10.1007/s12105-009-0127-0.
Captline AM, White NS, Merkow LP, Snyder SP. Atrophic luetic glossitis. Report of a case. Oral Surg Oral Med Oral Pathol. 1970;30(2):192–5. https://doi.org/10.1016/0030-4220(70)90360-9.
Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep. 2010;59(RR-12):1–110.
Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology. 3rd ed. London: Elsevier Limited; 2012.
Skerlev M, Culav-Koscak I. Gonorrhea: new challenges. Clin Dermatol. 2014;32(2):275–81. https://doi.org/10.1016/j.clindermatol.2013.08.010.
Randle HW. Treatment of oral ulcers. Dermatol Clin. 1993;11(4):801–8.
Bruce AJ, Rogers RS 3rd. Oral manifestations of sexually transmitted diseases. Clin Dermatol. 2004;22(6):520–7. https://doi.org/10.1016/j.clindermatol.2004.07.005.
Centers for Disease Control and Prevention (CDC). Update to CDC’s sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep. 2012;61(31):590–4.
Bignell C, Fitzgerald M. UK national guideline for the management of gonorrhoea in adults, 2011. Int J STD AIDS. 2011;22(10):541–7. https://doi.org/10.1258/ijsa.2011.011267.
Centers for Disease Control and Prevention (CDC). Tuberculosis outbreak associated with a homeless shelter – Kane County, Illinois, 2007–2011. MMWR Morb Mortal Wkly Rep. 2012;61(11):186–9.
Centers for Disease Control and Prevention (CDC). Notes from the field: tuberculosis cluster associated with homelessness – Duval County, Florida, 2004–2012. MMWR Morb Mortal Wkly Rep. 2012;61(28):539–40.
Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58(Rr-4):1–207.. quiz CE1-4
Toossi Z, Mayanja-Kizza H, Hirsch CS, Edmonds KL, Spahlinger T, Hom DL, et al. Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients. Clin Exp Immunol. 2001;123(2):233–8. https://doi.org/10.1046/j.1365-2249.2001.01401.x.
Brighenti S, Andersson J. Local immune responses in human tuberculosis: learning from the site of infection. J Infect Dis. 2012;205(Suppl 2):S316–24. https://doi.org/10.1093/infdis/jis043.
Mignogna MD, Muzio LL, Favia G, Ruoppo E, Sammartino G, Zarrelli C, et al. Oral tuberculosis: a clinical evaluation of 42 cases. Oral Dis. 2000;6(1):25–30.
Verma S, Prakash R, Mohan S, Singh U, Agarwal N. Primary oral tuberculosis. BMJ Case Rep. 2013; https://doi.org/10.1136/bcr-2013-010276.
Ishikawa H, Hyo Y, Ono T. Tuberculous submandibular lymphadenitis. J Oral Maxillofac Surg. 1982;40(5):302–5. https://doi.org/10.1016/0278-2391(82)90224-5.
Popowich L, Heydt S. Tuberculous cervical lymphadenitis. J Oral Maxillofac Surg. 1982;40(8):522–4. https://doi.org/10.1016/0278-2391(82)90017-9.
Garg RK, Singhal P. Primary tuberculosis of the tongue: a case report. J Contemp Dent Pract. 2007;8(4):74–80. https://doi.org/10.1016/S0278-2391(89)80019-9.
Centers for Disease Control and Prevention (CDC). Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. MMWR Morb Mortal Wkly Rep. 2011;60(48):1650–3.
American Thoracic Society, CDC, Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep. 2003;52(Rr-11):1–77.
Melnick SL, Roseman JM, Engel D, Cogen RB. Epidemiology of acute necrotizing ulcerative gingivitis. Epidemiol Rev. 1988;10:191–211.
Wade DN, Kerns DG. Acute necrotizing ulcerative gingivitis-periodontitis: a literature review. Mil Med. 1998;163(5):337–42.
Osuji OO. Necrotizing ulcerative gingivitis and cancrum oris (noma) in Ibadan. Niger J Periodontol. 1990;61(12):769–72. https://doi.org/10.1902/jop.1990.61.12.769.
Listgarten MA. Electron microscopic observations on the bacterial flora of acute necrotizing ulcerative gingivitis. J Periodontol. 1965;36:328–39. https://doi.org/10.1902/jop.1965.36.4.328.
Turnbull RS. Periodontal disease part IV: periodontal infections. Can Fam Physician. 1988;34:1399–400.
Cogen RB, Stevens AW Jr, Cohen-Cole S, Kirk K, Freeman A. Leukocyte function in the etiology of acute necrotizing ulcerative gingivitis. J Periodontol. 1983;54(7):402–7. https://doi.org/10.1902/jop.1983.54.7.402.
Claffey N, Russell R, Shanley D. Peripheral blood phagocyte function in acute necrotizing ulcerative gingivitis. J Periodontal Res. 1986;21(3):288–97. https://doi.org/10.1111/j.1600-0765.1986.tb01461.x.
Horning GM, Cohen ME. Necrotizing ulcerative gingivitis, periodontitis, and stomatitis: clinical staging and predisposing factors. J Periodontol. 1995;66(11):990–8. https://doi.org/10.1902/jop.1995.66.11.990.
Zitelli BJ, McIntire SC, Nowalk AJ. Zitelli and Davis’ atlas of pediatric physical diagnosis: expert consult – online. Philadelphia: Elsevier Health Sciences; 2012.
Pindborg JJ, Bhat M, Roed-Petersen B. Oral changes in South Indian children with severe protein deficiency. J Periodontol. 1967;38(3):218–21.
Uohara GI, Knapp MJ. Oral fusospirochetosis and associated lesions. Oral Surg Oral Med Oral Pathol. 1967;24(1):113–23. https://doi.org/10.1016/0030-4220(67)90297-6.
Falkler WA Jr, Martin SA, Vincent JW, Tall BD, Nauman RK, Suzuki JB. A clinical, demographic and microbiologic study of ANUG patients in an urban dental school. J Clin Periodontol. 1987;14(6):307–14. https://doi.org/10.1111/j.1600-051X.1987.tb00976.x.
Kliegman R. Nelson textbook of pediatrics. Philadelphia: Elsevier/Saunders; 2011.
Habif TP. Clinical dermatology. Philadelphia: Elsevier Health Sciences; 2009.
Ferri FF. Ferri’s color atlas and text of clinical medicine. Philadelphia: Saunders/Elsevier; 2009.
Baren JM, Rothrock S, Brennan J, Brown L. Pediatric emergency medicine. Philadelphia: Elsevier Health Sciences; 2007.
Murray PR, Rosenthal KS, Pfaller MA. Medical microbiology. Philadelphia: Elsevier Health Sciences; 2012.
Berk DR, Bayliss SJ. MRSA, staphylococcal scalded skin syndrome, and other cutaneous bacterial emergencies. Pediatr Ann. 2010;39(10):627–33. https://doi.org/10.3928/00904481-20100922-02.
Braunstein I, Wanat KA, Abuabara K, McGowan KL, Yan AC, Treat JR. Antibiotic sensitivity and resistance patterns in pediatric staphylococcal scalded skin syndrome. Pediatr Dermatol. 2014;31(3):305–8. https://doi.org/10.1111/pde.12195.
Marx J, Hockberger R, Walls R. Rosen’s emergency medicine – concepts and clinical practice. Philadelphia: Elsevier Health Sciences; 2013.
Global leprosy update, 2013; reducing disease burden. Wkly Epidemiol Rec 2014;89(36):389–400.
Cohen J, Opal SM, Powderly WG. Infectious diseases. Philadelphia: Elsevier – Health Sciences Division; 2010.
Rodrigues LC, Lockwood D. Leprosy now: epidemiology, progress, challenges, and research gaps. Lancet Infect Dis. 2011;11(6):464–70. https://doi.org/10.1016/S1473-3099(11)70006-8.
Motta AC, Komesu MC, Silva CH, Arruda D, Simão JC, Zenha EM, et al. Leprosy-specific oral lesions: a report of three cases. Med Oral Pathol Oral Cir Bucal. 2008;13(8):E479–82.
de Abreu MA, Michalany NS, Weckx LL, Neto Pimentel DR, Hirata CH, de Avelar Alchorne MM. The oral mucosa in leprosy: a clinical and histopathological study. Braz J Otorhinolaryngol. 2006;72(3):312–6.
Dhawan AK, Verma P, Sharma S. Oral lesions in leprosy revisited: a case report. Am J Dermatopathol. 2012;34(6):666–7. https://doi.org/10.1097/DAD.0b013e3182485bcc.
Girdhar BK, Desikan KV. A clinical study of the mouth in untreated lepromatous patients. Lepr Rev. 1979;50(1):25–35.
Bucci F Jr, Mesa M, Schwartz RA, McNeil G, Lambert WC. Oral lesions in lepromatous leprosy. J Oral Med. 1987;42(1):4–6.
Scheepers A, Lemmer J, Lownie JF. Oral manifestations of leprosy. Lepr Rev. 1993;64(1):37–43.
Costa A, Nery J, Oliveira M, Cuzzi T, Silva M. Oral lesions in leprosy. Indian J Dermatol Venereol Leprol. 2003;69(6):381–5.
Swain JP, Soud A, Agarwal SK. Necrotic erythema nodosum leprosum with oral mucosal involvement. Indian J Lepr. 2008;80(2):175–8.
Scheepers A, Lemmer J. Erythema nodosum leprosum: a possible cause of oral destruction in leprosy. Int J Lepr Other Mycobact Dis. 1992;60(4):641–3.. doi: 1299716
Martinez TS, Figueira MM, Costa AV, Gonçalves MA, Goulart LR, Goulart IM. Oral mucosa as a source of Mycobacterium leprae infection and transmission, and implications of bacterial DNA detection and the immunological status. Clin Microbiol Infect. 2011;17(11):1653–8. https://doi.org/10.1111/j.1469-0691.2010.03453.x.
Chimenos Kustner E, Pascual Cruz M, Pinol Dansis C, Vinals Iglesias H, RodrÃguez de Rivera Campillo ME, López López J. Lepromatous leprosy: a review and case report. Med Oral Patol Oral Cir Bucal. 2006;11(6):E474–9.
Ishii N, Barua S, Mori S, Nagaoka Y, Suzuki K. Report of the tenth meeting of the WHO Technical Advisory Group on Leprosy Control. Nihon Hansenbyo Gakkai Zasshi. 2010;79(1):37–42.
Chemotherapy of leprosy. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994;847:1–24.
Petersen PE, Bourgeois D, Ogawa H, Estupinan-Day S, Ndiaye C. The global burden of oral diseases and risks to oral health. Bull World Health Organ. 2005;83(9):661–9.
Tomar SL, Asma S. Smoking-attributable periodontitis in the United States: findings from NHANES III. National Health and Nutrition Examination Survey. J Periodontol. 2000;71(5):743–51. https://doi.org/10.1902/jop.2000.71.5.743.
Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366(9499):1809–20. https://doi.org/10.1016/S0140-6736(05)67728-8.
Slots J. Systemic antibiotics in periodontics. J Periodontol. 2004;75(11):1553–65. https://doi.org/10.1902/jop.2004.75.11.1553.
Robinson PG. The significance and management of periodontal lesions in HIV infection. Oral Dis. 2002;8(Suppl 2):91–7. https://doi.org/10.1034/j.1601-0825.2002.00019.x.
Newman MG, et al. Carranza’s clinical periodontology. Philadelphia: Elsevier – Health Sciences Division; 2014.
Quick CRG, et al. Essential surgery: problems, diagnosis, and management. Philadelphia: Elsevier – Health Sciences Division; 2013.
Marshall RI, Bartold PM. A clinical review of drug-induced gingival overgrowths. Aust Dent J. 1999;44(4):219–32. https://doi.org/10.1111/j.1834-7819.1999.tb00224.x.
Pihlstrom BL. Measurement of attachment level in clinical trials: probing methods. J Periodontol. 1992;63(12 Suppl):1072–7. https://doi.org/10.1902/jop.1992.63.12s.1072.
Markle W, Conti T, Kad M. Sexually transmitted diseases. Prim Care. 2013;40(3):557–87. https://doi.org/10.1016/j.pop.2013.05.001.
Velho PE, Souza EM, Belda JW. Donovanosis. Braz J Infect Dis. 2008;12(6):521–5. https://doi.org/10.1590/S1413-86702008000600015.
O’Farrell N. Donovanosis. Sex Transm Infect. 2002;78(6):452–7. https://doi.org/10.1136/sti.78.6.452.
O’Farrell N, Moi H. European guideline for the management of donovanosis, 2010. Int J STD AIDS. 2010;21(9):609–10. https://doi.org/10.1258/ijsa.2010.010245.
Rajendran R, Sivapathasundharam B. Shafer’s textbook of oral pathology. Philadelphia: Elsevier/Reed Elsevier; 2012.
Hanna CB, Pratt-Thomas HR. Extragenital granuloma venereum; report of six cases of lip, oral and cutaneous involvement with review of literature. S Med J. 1948;41(9):776–82.
Doddridge M, Muirhead R. Donovanosis of the oral cavity. Case report. Aust Dent J. 1994;39(4):203–5. https://doi.org/10.1111/j.1834-7819.1994.tb04776.x.
Brain P. Granuloma inguinale with extensive oral involvement. S Afr Med J. 1951;25(33):581–2.
Veeranna S, Raghu TY. Oral donovanosis. Int J STD AIDS. 2002;13(12):855–6. https://doi.org/10.1258/095646202321020170.
Hart G. Donovanosis. Clin Infect Dis. 1997;25(1):24–30.. quiz 31-2
Coovadia YM, Steinberg JL, Kharsany A. Granuloma inguinale (donovanosis) of the oral cavity. A case report. S Afr Med J. 1985;68(11):815–7.
Wysocki GP, Brooke RI. Oral manifestations of chronic granulomatous disease. Oral Surg Oral Med Oral Pathol. 1978;46(6):815–9. https://doi.org/10.1016/0030-4220(78)90313-4.
Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010;59(Rr-12):1–110.
Boyce JM. Recent trends in the epidemiology of tularemia in the United States. J Infect Dis. 1975;131(2):197–9.
Tarnvik A, Sandstrom G, Sjostedt A. Epidemiological analysis of tularemia in Sweden 1931–1993. FEMS Immunol Med Microbiol. 1996;13(3):201–4. https://doi.org/10.1111/j.1574-695X.1996.tb00237.x.
Ellis J, Oyston PC, Green M, Titball RW. Tularemia. Clin Microbiol Rev. 2002;15(4):631–46. https://doi.org/10.1128/CMR.15.4.631-646.2002.
Berdal BP, Mehl R, Meidell NK, Lorentzen-Styr AM, Scheel O. Field investigations of tularemia in Norway. FEMS Immunol Med Microbiol. 1996;13(3):191–5. https://doi.org/10.1111/j.1574-695X.1996.tb00235.x.
Ohara Y, Sato T, Fujita H, Ueno T, Homma M. Clinical manifestations of tularemia in Japan – analysis of 1,355 cases observed between 1924 and 1987. Infection. 1991;19(1):14–7. https://doi.org/10.1007/BF01643750.
Gurcan S. Epidemiology of tularemia. Balkan Med J. 2014;31(1):3–10. https://doi.org/10.5152/balkanmedj.2014.13117.
Pilo P, Johansson A, Frey J. Identification of Francisella tularensis cluster in central and western Europe. Emerg Infect Dis. 2009;15(12):2049–51. https://doi.org/10.3201/eid1512.080805.
Tularemia – United States, 2001–2010. MMWR Morb Mortal Wkly Rep 2013;62(47):963–6.
Senel E, Satilmis O, Acar B. Dermatologic manifestations of tularemia: a study of 151 cases in the mid-Anatolian region of Turkey. Int J Dermatol. 2014; https://doi.org/10.1111/ijd.12431.
Polat M, Kara SS, Tapısız A, Tezer H. Unusual presentation of oropharyngeal tularemia: a case report. Vector Borne Zoonotic Dis. 2013;13(5):337–9. https://doi.org/10.1089/vbz.2012.1184.
Dentan C, Pavese P, Pelloux I, Boisset S, Brion JP, Stahl JP, et al. Treatment of tularemia in pregnant woman. France Emerg Infect Dis. 2013;19(6):996–8. https://doi.org/10.3201/eid1906.130138.
Koc S, Gürbüzler L, Yaman H, Eyibilen A, Salman N, Ekici A. Tularaemia presenting as parapharyngeal abscess: case presentation. J Laryngol Otol. 2012;126(5):535–7. https://doi.org/10.1017/S0022215112000096.
Dlugaiczyk J, Harrer T, Zwerina J, Traxdorf M, Schwarz S, Splettstoesser W, et al. Oropharyngeal tularemia – a differential diagnosis of tonsillopharyngitis and cervical lymphadenitis. Wien Klin Wochenschr. 2010;122(3–4):110–4. https://doi.org/10.1007/s00508-009-1274-8.
Boisset S, Caspar Y, Sutera V, Maurin M. New therapeutic approaches for treatment of tularaemia: a review. Front Cell Infect Microbiol. 2014;4:40. https://doi.org/10.3389/fcimb.2014.00040.
Jackson LA, Perkins BA, Wenger JD. Cat scratch disease in the United States: an analysis of three national databases. Am J Public Health. 1993;83(12):1707–11.
Dehio C. Molecular and cellular basis of bartonella pathogenesis. Annu Rev Microbiol. 2004;58:365–90. https://doi.org/10.2105/AJPH.83.12.1707.
Cook GC, Zumla A. Manson’s tropical diseases. Philadelphia: Saunders; 2009.
Arisoy ES, et al. Hepatosplenic cat-scratch disease in children: selected clinical features and treatment. Clin Infect Dis. 1999;28(4):778–84.. NO DOI
Jacobs RF, Schutze GE. Bartonella henselae as a cause of prolonged fever and fever of unknown origin in children. Clin Infect Dis. 1998;26(1):80–4.. NO DOI
Farrar J, et al. Manson’s tropical diseases: expert consult – online. UK: Elsevier Health Sciences; 2013.
Margileth AM. Dermatologic manifestations and update of cat scratch disease. Pediatr Dermatol. 1988;5(1):1–9. https://doi.org/10.1111/j.1525-1470.1988.tb00876.x.
Moriarty RA, Margileth AM. Cat scratch disease. Infect Dis Clin N Am. 1987;1(3):575–90.
Steiner M, Gould A, Wilkie W, Porter K. Cat-scratch disease in the submandibular region: report of a case. J Oral Maxillofac Surg. 1994;52(6):614–8. https://doi.org/10.1016/0278-2391(94)90100-7.
Mintz SM, Anavi Y. Cat scratch fever presenting as a submental swelling. J Oral Maxillofac Surg. 1988;46(11):1015–8. https://doi.org/10.1016/0278-2391(88)90343-6.
Premachandra DJ, Milton CM. Cat scratch disease in the parotid gland presenting with facial paralysis. Br J Oral Maxillofac Surg. 1990;28(6):413–5. https://doi.org/10.1016/0266-4356(90)90042-J.
Margileth AM. Recent advances in diagnosis and treatment of cat scratch disease. Curr Infect Dis Rep. 2000;2(2):141–6. https://doi.org/10.1007/s11908-000-0026-8.
Brunetti E, Fabbi M, Ferraioli G, Prati P, Filice C, Sassera D, et al. Cat-scratch disease in Northern Italy: atypical clinical manifestations in humans and prevalence of Bartonella infection in cats. Eur J Clin Microbiol Infect Dis. 2013;32(4):531–4. https://doi.org/10.1007/s10096-012-1769-5.
Conrad DA. Treatment of cat-scratch disease. Curr Opin Pediatr. 2001;13(1):56–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Shelley, E.W., Torgerson, R.R. (2019). Oral Signs of Bacterial Disease. In: Fazel, N. (eds) Oral Signs of Systemic Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-10863-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-10863-2_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-10861-8
Online ISBN: 978-3-030-10863-2
eBook Packages: MedicineMedicine (R0)